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Abstract
Somatic effects of diethylstilbestrol on children exposed in utero have long 
been recognized. This is not the case for psychiatric disorders, although animal 
studies provide evidence of somatic and behavioral disorders. Recent studies 
have reported psychiatric effects of synthetic estrogens on the brain of chil-
dren exposed in utero as schizophrenia, bipolar disorders, depression, eating 
disorders, suicides, suicide attempts. Recently, a team of St. Anne’s Hospital, 
Paris (Prof. Krebs, Dr. Kebir) demonstrated the epigenetic mechanism of DES 
effect on the brain, a specific methylation of two genes playing important roles 
in neurodevelopment: the ADAM TS9 (control of the formation of reproductive 
organs and of the fetus’s CNS) and the ZFP 57 gene suggested to be associated 
with psychosis. Progestins used in contraception and in hormone replacement 
therapy are known to affect the adult brain, but no data on children existed 
before our recent paper on their effects after in utero exposure. Clinical data 
were collected from 1934 children of the Association of Patients HHORAGES 
cohort. Our data show the presence of somatic disorders and a drastic increase 
of psychiatric disorders among children in utero exposed to progestins. These 
mental disorders are the same as pathologies provoked by exposure to synthetic 
estrogens.
Keywords: synthetic estrogens, diethylstilbestrol, ethinyl estradiol, 
synthetic progestins, mental disorders, in utero exposure
1. Introduction
At the end of the 1990s, somewhere in France, an agricultural engineer, 
Mr. RA, made the observation that his three children were suffering from  various 
psychic and somatic pathologies, the elder suffering from bilateral cryptor-
chidism, micropenis, infertility due to azoospermia (no spermatozoa), and 
schizotypal character; the second from anxiety, depression, and eating disorders 
(anorexia) coupled with small uterus and ovaries; and the third suffering from 
Psychopathology - An International and Interdisciplinary Perspective
2
schizophrenia and severe depression associated with suicide attempts. He observed 
also the relationship with the fact that in all three cases, his wife received medical 
treatment consisting of a synthetic hormone cocktail: diethylstilbestrol (DES), 
ethinyl estradiol (EE), plus synthetic progestin delay during her three pregnan-
cies after a previous miscarriage. He conducted research in the world literature on 
the subject and came to the conclusion that not only was one of these products, 
diethylstilbestrol (DES), already known for its misdeeds but that it continued to 
be administered in France until 1977/1982. The product, inexpensive to make, 
was not patented and was manufactured and distributed by many pharmaceutical 
laboratories. The same goes for EE, which was banned for pregnant women in 1980 
but remains the best-selling estrogen in the world because it is part of the contra-
ceptive pill.
In 1998, one of us (MOS-G), concerned by the same kind of problems in her 
two children who were exposed in utero to the same cocktail of synthetic estro-
gens, lost her two children after psychiatric illnesses. Following the reading of 
a “Call to Families” printed in a newspaper, she met Mr. RA, who had gathered 
around him about 20 French families concerned with their in utero-exposed 
children suffering from psychiatric illnesses. He wanted to expose his observations 
and the results of his bibliographic researches at a meeting of patient families 
collecting observations on the genital malformations of girls exposed in utero 
to DES. Alas, he was condemned, rejected, and disclaimed by doctors, mostly 
gynecologists and psychiatrists as well as by associative members. They denied 
the existence of psychiatric disorders in exposed boys and girls. Discouraged, 
Mr. RA died shortly afterward. In order to continue his work and regroup the 
families concerned by the origin of the heavy psychiatric pathologies of their 
children and despite the taboo surrounding such diseases as psychoses, we gath-
ered several mothers concerned and created the Association of Patients Halt to 
Artificial Hormones for Pregnancies (HHORAGES), in 2002. This Association 
which collected more than 1300 French spontaneous testimonies is now registered 
with the Epidemiology Portal of French National Institute for Medical Research 
(INSERM) as a French Health Database.
Despite various alerts published in the 1940s, after work on animals proving 
in particular its carcinogenic effect, and despite the work of Dieckman et al. [1], 
initiated as early as 1953, demonstrating in a large cohort of pregnant women given 
diethylstilbetrol (DES), a synthetic estrogen, versus placebo that the drug was inef-
ficient in preventing miscarriages or premature births, this product has been widely 
distributed around the world, sowing a long list of misdeeds. After the discovery 
of cervicovaginal cancers called “clear cells adenoma (CCAD)” [2] in the “DES 
girls,” DES was banned in the United States for pregnant women in 1971 but only 
in 1977 in France, where this recommendation disappeared from the “French Vidal 
book,” but DES continued to be prescribed sporadically until 1982. Meanwhile 
another synthetic estrogen, steroidal, also synthesized on 1938, 17-alpha-ethinyl 
estradiol (EE), was often added to DES as a cocktail or later as a replacement, some-
times with the addition of synthetic-delay progestin. The idea that prevailed at the 
time was that women had a hormonal deficit that triggered a miscarriage, whereas 
now we know that the miscarriage itself causes this deficiency. These products were 
prescribed not only to women who had miscarriages but also in comfort (“to have 
beautiful babies,” according to an advertising) or even as a “morning after pill” or 
to cut milk after childbirth. DES and 17-alpha-EE, although belonging to different 
estrogenic and degrading categories, are, however, bound to the same ER beta-
estrogen receptors.
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2. Behavioral disorders demonstrated in animals (rats) exposed in utero
Animal studies (on mice and rats) have demonstrated the toxicity of these 
synthetic estrogens on the offspring, including the cause of behavioral disorders 
[3–8]. Palanza et al. [3] demonstrated in particular that prenatal exposure to three 
different synthetic chemicals, DES and two pesticides, DDT and methoxychlor, and 
its analog, affects the behavior of young suckling mice, showing increased aggres-
sion in males (increased numbers of attacks and decreased reaction time before 
the attack) (Figure 1). Doses of DES were 1000 times less than those of DDT and 
caused much larger aggression responses, demonstrating the considerable effect of 
DES at very low doses. The treatment period for rodent mothers from day 11 to day 
17 of pregnancy was also critical because it represents a key period in the differen-
tiation of the reproductive system and brain development in these rodents in the 
early stages of pregnancy.
Moreover, injection of 17-alpha-estradiol (EE) in pregnant rats causes not only 
many abortions in mothers but also anxiety and depression disorders in offspring 
[4, 5], the synthetic hormone having been administered at the same relative doses 
as in humans (15 g/kg, 1 per day, versus 19 g/kg, 1 per day). At the cytological 
level of the brain, an alteration of the anterior part of the hippocampus in young 
rats exposed to EE in utero has been demonstrated in 2004 [6]. The hippocampus 
is indeed a part of the brain that contains many estrogen receptors during the 
prenatal period. Ogiue-Ikeda et al. [7] showed in 2008 that synaptic plasticity can 
Figure 1. 
Measurement of aggressiveness in young male mice after prenatal exposure to diethylstilbestrol (DES) (0.02 
and 0.2 μg/kg) [in gray], DDT [20 and 200 μg/kg] [in black], with a control without DES [in white]. There 
is an increase in the number of attacks and a decrease of the reaction time before the attack although the doses 
of DES are 1000 times less than those of DDT. According to Palanza et al. [3], with the permission of Elsevier 
(License No: 2514671323242).
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be upset by estrogens or other endocrine disruptors (EDs). Later and unequivo-
cally, Newbold demonstrated the validity of the rodent model transposed to 
humans [8].
3.  Behavioral disorders, psychoses, and depression demonstrated in 
humans after in utero exposure to DES/EE
In humans, the work concerning the appearance of behavioral disorders in 
children after in utero exposure to synthetic hormones is less numerous, but as 
early as 1977, June Reinisch [9] published in Nature that prenatal exposure to 
estrogen and/or synthetic progestins could affect the personality of exposed 
children. More recently, in 2012, Kebir and Krebs [10] have analyzed several 
epidemiological studies concerning the effects of DES on exposed children in 
utero and the occurrence of psychiatric disorders in these children. Their analysis 
shows that only three large epidemiological studies on the effects of DES were 
performed in 1952–1953 (followed up in 1983), in 2007, and in 2010. The first 
study (double-blinded) that supports the hypothesis of a link between psychiatric 
disorders and prenatal exposure to DES was performed by Vessey et al., in 1983 
[11], from a clinical trial that had been performed 30 years earlier in 1953 in 
London by Dieckman et al., on 700 women treated with DES versus 700 subjected 
to a placebo [1]. A doubling of depression and anxiety disorders has been 
demonstrated in the population exposed in utero. The second, published in 2007 
and conducted by Verdoux et al. [12], from a cohort of women from the Mutuelle 
(Health) de l’Education Nationale (MGEN) concludes that there are no significant 
links between exposure to DES, suicides, and/or psychiatric consultations or 
hospitalizations. A detailed analysis later, however, revealed a number of biases in 
this study [13]. The most recent Nurses’ Health Study was conducted by O’Reilly 
et al., 2010 [14], from 76,240 American women among whom 1612 women were 
exposed to DES in utero. The statistical analysis shows that the latter experienced 
an increase in depressive and anxiety disorders by a factor of 1.3. Kebir and Krebs 
[10] emphasized the limitations of such epidemiological studies and noted in 
particular that, apart from depression and anxiety, other psychiatric disorders 
have not been studied. Postadolescence behavioral disturbances reported for 
these two estrogens in exposed children were depression [15, 16], anxiety [1, 
11, 17], schizophrenia-like behavior [18, 19], anorexia, and bulimia nervosa 
[20]. All these observations were synthesized by Pillard et al. [16] and Giusti 
[21]. On 1987, Katz et al. [18] described the case of four male adults prenatally 
exposed to DES. It is in late adolescence that they develop psychotic disorders 
requiring neuroleptic treatment even though they have no family history of 
this type. He then hypothesizes that there may be a causal relationship between 
disruptions in neurodevelopment related to DES and the subsequent onset of 
psychotic disorders. Pillard et al. [16] showed that the frequency of recurrent 
major depressive episodes is significantly higher in the DES-exposed than in their 
unexposed siblings, which was confirmed in 2010 in the large cohort of DES girls 
by O’Reilly et al. [14].
Investigation of the causal link between exposure to these synthetic hormones in 
utero and severe psychotic disorders such as schizophrenia, bipolar disorders with 
or without eating disorders, and schizoaffective disorders, occurring in post-
adolescence in exposed children, was made possible thanks to the families of the 
Association HHORAGES. Our database, constituted by these spontaneous families’ 
testimonies, is based on responses to a detailed questionnaire, written by doctors 
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and researchers and accepted by the CNIL (French Center for the Protection of 
Data Processing and Freedom). Our first global analysis (2004–2005 data) was 
based on 967 pregnancies from 470 mothers in collaboration between 2 of us 
(MOS-G/CS) of us (CS). The first results as well as the family questionnaires were 
detailed in 2012 in the chapter published in 2012 by InTech “Behavioral and Somatic 
Disorders in Children Exposed In Utero to Synthetic Hormones” [13] in which 
we detailed somatic and psychiatric disorders, associated or not, in the exposed 
children of our cohort.
We have conducted a more recent analysis (2016) [22, 23] based on 1182 
 pregnancies from 529 mothers (Figure 2).
Among the 740 (20 stillborn) exposed children, 603 (exposed) +16 post-DES 
(born without exposure but after a previous exposed pregnancy) are suffering from 
psychiatric disorders. The prevalence of the psychiatric disorders in comparison 
with the general population shows a dramatic increase (Table 1).
We were also interested by the effects on the brain of synthetic progestins on 
in utero-exposed children of our cohort (Figures 3 and 4). Currently, there is no 
research on these effects of in utero exposure of children to progestins given alone 
during pregnancy. Our recent observations [24, 25] were collected from 1200 
families of the HHORAGES cohort, that is, 1934 children using always the same 
detailed questionnaire [13]. As previously shown, most families of our cohort had 
children exposed to estrogens or to estro-progestins, but only 46 families (115 
children) had at least 1 child exposed to 1 or more progestins prescribed alone and 
representing 62 in utero-exposed children. Thirty-five children were post-exposed 
(Figure 3). The prescribed progestins were 17-α-hydroxyprogesterone caproate 
(synthetic progestin, SP) against total indication in 2000 but reauthorized in 2011, 
17-α-hydroxyprogesterone heptanoate (SP) against total indication in 2002, and 
chlormadinone acetate (SP), derived from hydroxyprogesterone, against total 
indication in 1970.
Among the 62 exposed children (22 girls and 40 boys), 49 presented psychiatric 
disorders, 6 presented somatic disorders only, and 7 did not present any disorder. 
Only 1 post-exposed presented psychiatric disorder, while 34 other post-exposed 
did not present any disorder.
Among the 49 children affected by psychiatric disorders, 3 boys and 7 girls 
presented both somatic disorders in addition to psychiatric ones: boys (3), hypo-
spadias (1), no urinary meatus (1), bilateral cryptorchidia, and sexual ambiguity 
(1) and girls (7), hormonal sterility (2), hirsutism and enuresis (1), enuresis (1), 
hirsutism (1), hermaphrodism (1, operated), and sexual ambiguity and tight 
Figure 2. 
Total number of psychological/psychiatric disorders among the 982 (1002 total with 20 stillborns) DES-exposed 
and post-DES unexposed children. First-born children (intrafamilial control) unexposed are not ill.
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urethra (1). Among the six exposed children suffering from somatic disorders 
“only,” we observed for boys (four) mega bilateral ureter (one grandchild), 
unilateral  cryptorchidia (one), hypospadias with numerous interventions of 
Figure 3. 
Total HHORAGES cohort of 1934 children in which 3 groups can be observed.
Figure 4. 
Division of the 115 children of the 46 “progestins” families: first-born unexposed, in utero exposed, and post 
exposed, that is, born after a previous exposed pregnancy.
Group 1 Group 2 Group 3
First-born 
pre-DES
DES-exposed Post-DES General 
population
n = 180 n = 740-20 n = 262
Behavioral disorders 0% n = 109 (15.1%) n = 1 (0.4%) 3%
Schizophrenia 0% n = 165 (22.9%) n = 6 (2.3%) 1%
Eating disorders 0% n = 81 (11.3%) n = 2 (0.8%) 1.6%
Depression
Bipolar disorders, anxiety 0% n = 248 (34.4%) n = 9 (3.4%) 6.3%
Suicide attempts 0% n = 612 (85%) n = 30 (11.5%) 0.3%
Death 0% n = 32 (4.4%) n = 1 (0.4%) 0.02%
Table 1. 
Prevalences of the psychological and/or psychiatric disorders in in utero-exposed children to DES and/or EE 
and comparison with the general population [23].
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reconstruction (one grandchild), and sexual ambiguity (one) and for girls (two) 
hormonal sterility (two).
As shown in Figure 5, a comparison of synthetic estrogen and progestin 
exposures for girls and boys demonstrates that psychiatric disorders were of the 
same nature for progestin exposure as those observed after exposure to synthetic 
estrogens, that is, behavioral disorders = 2, eating disorders = 2, schizophrenia = 29, 
depression, bipolar disorders = 16, suicides attempts = 7 series, and death = 1. 
The percentage of suicide attempts (11.29%) and death after suicide (1.6%) is 
proportionately lower after exposure to progestins than after exposure to synthetic 
estrogens.
4. An epigenetic mechanism
Search for the molecular basis of the causal link between in utero, exposure to 
synthetic hormones and the appearance of psychoses as schizophrenia or bipolar 
disorder in children exposed in utero, has been achieved thanks to the partnership 
that unites HHORAGES Patients’ Association with the INSERM team of molecu-
lar psychiatrist Pr. MO Krebs (St. Anne’s Hospital, Paris, France, UMR S 894), 
which began in 2007. “It would have been ‘crazy’ to miss the problem posed by the 
Association Hhorages to establish a causal link between taking artificial hormone 
(s) during pregnancy and appearance of psychiatric disorders of the type psychotic 
in exposed children, because diethylstilbestrol (Distilbene® or DES) has been given 
over a limited period of time and people who have taken this molecule are still there 
to testify. This is a case study that should not be missed” said Dr. Kebir (Center for 
Psychiatry and Neuroscience, UMR S 894), manager of these researches as part of 
the Krebs’ team.
Figure 5. 
Comparative diagrams representing psychiatric disorder cases presented, respectively, by girls (a, c) and boys 
(b, d) exposed either to synthetic estrogens diethylstilbestrol (DES) and ethinyl estradiol (EE) (c, d) or to 
synthetic progestins (a, b).
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First, to document in utero exposure to synthetic estrogens, Kebir and Krebs 
[10] were able to analyze from our data a small number of family records that 
occurred in HHORAGES testimonies and studied a cohort of 472 exposed subjects. 
They account for 46.7% of mood disorders, 22.9% of psychotic disorders, 6.6% of 
anxiety disorders, 11% of eating disorders, and 12.7% of others, which confirms 
their previous observations published on 2009 and 2010 at the seventh and eighth 
Congress of the Encephalon in Paris [26, 27] on 43 exposed children highlighting 
clinical pictures with atypical associations.
Second, genetic and epigenetic analyses of HHORAGES siblings have shown 
in patients suffering from psychotic disorders and exposed in utero to DES and/
or EE that this prenatal exposure is associated with epigenetic processes. Starting 
from the fact that psychiatric diseases develop from a brain dysfunction  during 
neurodevelopment, and knowing that DES and EE are synthetic hormones 
(estrogens), endocrine disruptors, and confirming from the HHORAGES data 
numerous cases of heavy psychiatric disorders in children exposed, the Krebs’team 
in association with HHORAGES designed 10 years ago, in 2007, a research project 
Partnership Citizen Institution for Research and Innovation (PICRI), funded by 
the Ile de France Region, net by the French National REsearch Agency (ANR), that 
developed the hypothesis that the DES administered during pregnancies could 
be an environmental risk factor for the development of psychiatric disorders in 
impregnated children: the epigenome of the foetus could have been modified by 
in utero exposure to synthetic estrogens. The PICRI project was titled “Influence 
of hormonal treatments on brain development during pregnancy: study of phe-
notypic, behavioral and biological changes in informative families.” The families 
of HHORAGES were called to perform peripheral blood sampling after thorough 
questioning. Many families volunteered to participate in the research: 31 families 
were selected, satisfying the rigorous inclusion criteria desired. Many more fami-
lies had come forward during this study, but they could not be included because 
the psychotic patient refused to come to St. Anne’s Hospital for blood sampling. 
In the selected families, total siblings were composed of first-born unexposed 
children, exposed children, and post-exposed children, with first-born unexposed 
serving as intrafamilial control. For the exploration of their epigenome, 485,000 
cytosines by genome were studied and analyzed, representing an immense work. 
To complete this study, a cohort of young adolescents with relational, emotional, 
and social difficulties was followed for 6 months, some of whom had developed 
schizophrenic-type psychosis in these 6 months, although not exposed to DES. A 
comparison of their methylome, analyzed before and after the onset of the disease, 
was performed. In this study [28], authors reported a global methylation of the 
psychotic patient genome.
After the analysis of the whole methylome of the selected HHORAGES cohort, 
the team of Krebs-Kebir highlighted differential specific methylated regions 
(DMR): in the zinc finger protein 57 gene ZFP57 and in the ADAM TS9gene and 
in young psychotic patients exposed in utero to DES/EE [29, 30]. In this work, 
the authors observed that in exposed individuals, ZFP57 gene methylation may 
be associated with their psychosis. The ZFP57 gene (located on chromosome 6) is 
expressed very early in development. It is a transcription regulator, directly related 
to the phenomenon of methylation and neurodevelopment [31]. The ADAM TS9 
gene is implicated in the control of organ shape, especially in the development and 
function of the uterus and reproductive organs [32] which are often abnormal after 
in utero DES exposure as well as in the control of the CNS development [33] and in 
several kinds of cancers [34].
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5. Discussion and conclusion
Very few studies have investigated the impact of prenatal exposure to DES and EE 
on psychiatric outcome. Animal studies on rats or mice allowed us to hypothesize that 
estrogenic hormones induce neurodevelopmental disturbances in exposed human 
subjects and may potentially mediate an increased risk of behavioral and psychiatric 
disorders. Our data therefore strongly suggest that DES/EE exposure during pregnancy 
is associated with high incidence of behavioral and/or psychiatric disorders. They illus-
trate a higher risk of schizophrenia, as this disease was 17 times more prevalent than in 
the general population, with sons being more affected than DES daughters. Regarding 
the existence of eating disorders (bulimia, anorexia), it should be noted that girls 
are much more affected than boys, and we often observed the association of eating 
disorders with bipolarity (manic-depressive disorders), anxiety, and depression. With 
regard to suicides, our work clearly demonstrates a drastically increased risk of suicide 
attempts (65.4% versus 0 in the unexposed controls and 0.25% in the general popula-
tion) and suicides (3.4% versus 0 in the unexposed controls and 0.02% in the general 
population). It could be noted that, as in the general population, DES sons commit 
more suicides than DES daughters and the inverse for suicide attempts. Moreover, our 
data reveal that 50% of the sons who committed suicide suffered from schizophrenia. 
Psychiatric studies in general have shown that the percentage of suicides is generally 
higher in individuals with psychiatric disorders than in the general population. But 
to our knowledge, there is no information or specific studies concerning this associa-
tion in the context of DES exposure. Sixteen subjects in Group 3 (post-DES children) 
(Figure 2 and Table 1) had diagnosed psychiatric disorders. An explanation for this 
finding might be that DES, being a very lipophilic synthetic estrogen, remains in 
the mothers’ fat after estrogenic impregnation in a previous pregnancy and is then 
released through the placental barrier during the next gestation.
No work had been reported on the impact of in utero exposure to synthetic 
progestin hormones administered alone on the occurrence of psychiatric disorders 
in exposed children before our first presentation in the European Congress of 
Gynecology in 2017 [24]. For the first time, we described psychiatric disorders that 
can affect children exposed in utero to progestins. Previously, and during many 
years, synthetic progestogens were not considered as dangerous during pregnancy 
or during replacement or contraceptive treatment. Moreover, they have been 
suggested to exert neuroprotective effects in several animal models of neurological 
disease [35]. Negative mood symptoms have been reported by Andreen et al. [36] 
in some women as a result of progesterone during the luteal phase of menstrual 
cycles. This is believed to be mediated via the action of allopregnanolone on the 
GABA-A system. A reduction of allopregnanolone circulating levels that correlates 
to depressive symptoms has been recently reported [37], and conversely, healthy 
women reported increased anxiety and mood disorders after long-acting subder-
mal implant of progestogens. In a group of 236 schizophrenic patients at onset, 
an elevated concentration of progesterone has been found, and authors suggested 
that steroid hormones may influence brain function, underlying schizophrenia, 
and major depressive disorders [38]. Moreover, Buoli et al. (2016) found high 
DHAS levels in patients with a history of psychotic symptoms, suggesting a role of 
steroids in the etiology of psychosis and mood disorders [39]. Progestins are known 
to induce GABA receptor activity/neural activation before birth; it is likely that a 
GABAergic system could contribute to schizophrenia, anxiety, depression, panic 
disorders, epilepsy, autism, and others [40]. Although some progestins have been 
banned from the market, others are not: our data demonstrated that caution should 
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be taken with regard to the use of these progestins during pregnancy and even 
outside these periods (contraception or hormone replacement therapy).
The brain is a very vulnerable organ because its development covers a very broad 
period extending from the early prenatal stage (third week of pregnancy) to end 
around the age of 20. During its development, there are times when its vulner-
ability is even greater than others; these periods are called “shooting windows,” 
during which the environment can impact the normal process of development. 
Abdolmaleky et al. [41] as early as 2005 had developed the hypothesis that gene-
environment modulations could be performed via DNA methylations. Krebs’ team 
put forward the hypothesis that DES-induced changes in epigenetic background 
and alteration of DNA functioning (methylations) could be significant factors to 
demonstrate a possible origin of psychotic disorders and a link with in utero DES 
exposure of the children suffering from these illnesses [29, 30].
Numerous studies have shown that, for example, in the rat, early maternal sepa-
ration or the fact of causing significant stress to the mother changes the methylation 
signals of certain genes of the rat directly related to the regulation of anxiety. It has 
also been discovered that the proper environment for changing the methylation sig-
nals may be chemical. This is the case of DES recognized by the scientific community 
as an endocrine disruptor and banned for pregnant women. This change in the level 
of methylation caused in utero by DES has been demonstrated for urogenital mal-
formations of girls and boys as well as for cancers. On 2015, Harlid et al. published 
in a pioneer work the first study for evaluation of possible effects of in utero DES 
exposure on genome-wide DNA methylation in humans [42]. They studied whole 
blood DNA methylation in 100 40–59-year-old women reporting in utero exposure, 
compared to 100 unexposed women. They did not find any differential methyla-
tion, but the DMR approach was not used in their recent work (2015). On the other 
hand, in 2017 Rivollier et al. [30] described specific differential methylated regions 
(DMR) on two genes implicated in neurodevelopment (ZFP57 and ADAMTS9). 
Surprisingly, they cautiously claim that these DMR are “supposedly” associated 
with prenatal exposure to DES in young psychotic patients in utero exposed to DES/
EE. Nevertheless, these modifications of methylation are really specific because they 
do not exist in the methylome of young psychotic patients not exposed to DES [28] 
in which global methylation of the genome was observed. Moreover authors have 
compared exposed subjects to their unexposed siblings which do not present these 
specific methylations although they shared environmental and genetic factors.
The citizen work carried out between the French HHORAGES Patient Association 
and two major medical research laboratories has provided convincing scientific 
results: (1) on the detection and confirmation of the existence of psychiatric dis-
orders (accompanied or not of somatic disorders) in children exposed in utero to 
synthetic hormones and (2) on the mechanisms of action of these synthetic hormones 
administered to pregnant mothers on the brain of their offspring. The effects of these 
endocrine disruptors in humans through what is becoming a public health scandal, 
denied for a long time by doctors, especially psychiatrists, scientists, and special-
ized journalists, are thus better known. The fact that these synthetic products do not 
degrade in the human body in the same way as the natural hormones [13] and act on 
the functioning of genes implicated in neurodevelopment during the fetal life, follow-
ing an epigenetic mechanism, is a real time bomb. Indeed, this mechanism induces 
a transgenerational effect already partially demonstrated in the HHORAGES cohort 
at the third-generation level for hypospadias, a specific genital malformation. So far, 
only a few third-generation children suffering psychiatric illness are documented 
in the HHORAGES testimonies. This is understandable because third-generation 
exposed children are still too young (excepted in some cases) to present psychiatric 
disorders as schizophrenia which is not the case for hypospadias that are detectable 
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from birth in male children and grandchildren [43]. In contrast, psychiatric disorders 
usually appear in postadolescence, 18–20 years, and sometimes later.
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